Who is sponsoring NCT03594942?

NCT03594942 is sponsored by Services Hospital, Lahore.

What drugs are being tested in NCT03594942?

Interventions in NCT03594942: procto sigmoidoscopy and biopsy if required.

What condition does NCT03594942 study?

NCT03594942 studies Rectal Bleeding.

Is NCT03594942 still recruiting?

NCT03594942 is currently status unknown. Last updated 20 July 2018.

Last reviewed 2018-07-20 · How we verify

NCT03594942

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Diagnostic Outcomes of Patients Presenting With Per Rectal Bleed in Surgical Departments of Services Hospital Lahore

Status unknown Last updated 20 July 2018

What this trial tests

trial testing procto sigmoidoscopy and biopsy if required in Rectal Bleeding in 100 participants. Status unknown.

Timeline

1 January 2018

Primary endpoint
1 August 2018

1 August 2018

Quick facts

Lead sponsor	Services Hospital, Lahore
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	100
Start date	1 January 2018
Primary completion	1 August 2018
Estimated completion	1 August 2018
Sites	1 location across Pakistan

Drugs / interventions tested

procto sigmoidoscopy and biopsy if required

Conditions studied

Rectal Bleeding — all drugs for Rectal Bleeding →

Sponsor

Services Hospital, Lahore

Who can join

12 and older, any sex, with Rectal Bleeding. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

It is a cross sectional study in which investigators will be recruiting patients of any sex above 12 years of age who will present to surgical outdoor with per rectal bleed. Investigators will then follow them through investigations to reach a certain diagnosis. Then investigators will be able to compile the data of diseases and their frequency, which are presenting with rectal bleed in their setup.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Services Hospital, Lahore trials

Trials by the same sponsor.

NCT06239207 — Efficacy and Safety of Exosomes Versus Platelet Rich Plasma in Patients of Androgenetic Alopecia · Phase 2 · completed
NCT07395388 — Intraoperative Methylene Blue Spray for the Identification and Preservation of Vital Structures in Thyroidectomy · NA · completed
NCT05714423 — Outcomes in Lower Pole Kidney Stone Management Using Mini-PCNL Compared With Retrograde Intra Renal Surgery · NA · completed
NCT07473388 — Clipless Versus Conventional Laparoscopic Cholecystectomy Using Harmonic Scalpel · NA · completed
NCT07493343 — EUSOL vs. PDGF Dressing for Diabetic Foot Ulcers · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03594942 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Services Hospital, Lahore
Last refreshed: 20 July 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03594942.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing